What was Assembly Biosciences’s price range in the past 12 months?
Assembly Biosciences lowest stock price was €7.09 and its highest was €24.00 in the past 12 months.
What is Assembly Biosciences’s market cap?
Currently, no data Available
When is Assembly Biosciences’s upcoming earnings report date?
Assembly Biosciences’s upcoming earnings report date is Mar 07, 2024 which is 42 days ago.
How were Assembly Biosciences’s earnings last quarter?
Assembly Biosciences released its earnings results on Nov 08, 2023. The company reported -€3.004 earnings per share for the quarter, missing the consensus estimate of -€2.615 by -€0.389.
Assembly Biosciences does not currently pay dividends.
What is Assembly Biosciences’s EPS estimate?
Assembly Biosciences’s EPS estimate is -€2.61.
How many shares outstanding does Assembly Biosciences have?
Currently, no data Available
What happened to Assembly Biosciences’s price movement after its last earnings report?
Assembly Biosciences reported an EPS of -€3.004 in its last earnings report, missing expectations of -€2.615. Following the earnings report the stock price went down -14.243%.
Which hedge fund is a major shareholder of Assembly Biosciences?
Among the largest hedge funds holding Assembly Biosciences’s share is Platinum Investment Management. It holds Assembly Biosciences’s shares valued at N/A.
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.
Copying Salim Syed's trades and holding each position for 1 Year would result in 3.85% of your transactions generating a profit, with an average return of -44.22% per trade.